Presentation is loading. Please wait.

Presentation is loading. Please wait.

Chapter 37 Aminoglycosides

Similar presentations


Presentation on theme: "Chapter 37 Aminoglycosides"— Presentation transcript:

1 Chapter 37 Aminoglycosides

2 History 1944 Streptomycin 1957 kanamycin 1964 gentamicin
1967 tobramycin Amikacin & netilmicin

3 General properties of Aminoglycosides

4 Phsical and chemical properties
Structure Water-soluble, stable in solution More active at alkaline than at acid pH

5 Antibacterial spectrum
High activity against aerobic G- rods Effective on MRSA netilmicin Less active on gram-negative cocci P.aeruginosa: gentamicin,tobramycin, amikacin and netimicin Resisant to enterococci and anaerobe Mycobacteria: streptomycin, kanamycin

6 Mechanism of Action Inhibit protein synthesis irreversibly interfering with the initiation complex of peptide formation induce misreading of mRNA,resulting in nonfunctional protein inhibit the break of 70s initiation complex Increasing the permeability of cell membrane

7 Mechanism of resistance
Produce enzyme that inactivate the aminoglycoside by adenylylation, acetylation and phosphorylation Impared entry of aminoglycoside into the cell Alteration of target protein

8 Pharmacokinetics Absorption: po poorly, im, iv Distribution :
low concentration in most tissue except renal cortex Can pass placental barrier, ×BBB Excretion: in unchanged form by glomerular filtration

9 Clinical uses Infections caused by sensitive G- rods
Topical infections Tuberculosis Infections caused by P. aeruginosa

10 Adverse reactions Dangerous factors:
Using continuously more than 5 days High dose Eldly and children Renal insufficiency Concurrent use with loop diuretics or other nephrotoxic drugs

11 Adverse reactions Ototoxicity Nephrotoxicity Neuromuscular blockade
Auditory damage:tinnitus, hearing loss Vestibular damage:vertigo, ataxia and loss of balance Nephrotoxicity Neuromuscular blockade neostigmine and calcium gluconate Allergic reactions

12 The commonly used aminoglycosides

13 Streptomycin Clinical uses Tuberculosis first line
Plague, tularemia and brucellosis: combination with tetracycline Enterococcal and viridans streptococcal endocarditis: combination with penicillin G

14 Gentamicin Clinical uses
Severe infections caused by gram-negative bacteria such as pseudomonas, enterobacter, serratia, proteus(变形杆菌), acinetobacter(不动杆菌) and klebsiella P.aeruginosa infections: combination with carbenicillin Endocarditis Bowel preparation for elective surgery

15 Kanamycin Topical administration
Oral administration in preparation for elective bowel surgery

16 Tobramycin Similar antibacterial spectrum with gentamicin
More active against P.aeruginosa Treat infections caused by P.aeruginosa that are resistant to gentamicin

17 Amikacin The most wide antibacterial spectrum
Resistant to many enzyme that inactivate gentamicin and tobramycin

18 Netilmicin Resistant to many enzyme that inactivate gentamicin and tobramycin Lowest toxicity among aminoglycosides

19

20

21

22

23

24

25


Download ppt "Chapter 37 Aminoglycosides"

Similar presentations


Ads by Google